Stock Events

Stock Events

Bachem 

€80.45
0
-€0.25-0.31% Today

Statistics

Day High
80.45
Day Low
80.45
52W High
81.1
52W Low
22.96
Volume
0
Avg. Volume
5
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.6%
Dividend
0.48

Upcoming

4
MAY
Dividend Ex
Increased
 
4
MAY
Dividend Ex
 
6
MAY
Dividend Payment
Increased
 
6
MAY
Dividend Payment
 
4
MAY 27
Dividend Ex
Estimated
 

Dividends

0.6%Dividend Yield
May 26
€0.49
May 26
€0.49
May 25
€0.46
Apr 24
€0.41
Apr 23
€0.38
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

12MarExpected
Q4 2025
0.96
1.3
1.63
1.96
Expected EPS
0.9636742808
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BHM0.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap189.22B
Amgen is a biotechnology company that competes with Bachem in the development and manufacturing of peptide-based therapeutics.
Lilly(Eli) &
LLY
Mkt Cap840.84B
Eli Lilly is a pharmaceutical company with a strong focus on peptide and protein-based drugs, directly competing with Bachem's peptide synthesis services.
Novo Nordisk
NVO
Mkt Cap167.44B
Novo Nordisk specializes in diabetes care and biopharmaceuticals, including peptide treatments, making it a competitor in the peptide therapeutic market.
Pfizer
PFE
Mkt Cap153.13B
Pfizer is a global pharmaceutical corporation that competes with Bachem in the development and production of peptide and protein-based drugs.
Merck
MRK
Mkt Cap300.2B
Merck is a healthcare company that develops peptide-based therapeutics, competing with Bachem in the biopharmaceutical sector.
Sanofi
SNY
Mkt Cap113.88B
Sanofi is a global pharmaceutical company that develops peptide-based drugs, competing with Bachem in the peptide therapeutics market.
Astrazeneca
AZN
Mkt Cap316.3B
AstraZeneca is a biopharmaceutical company that competes with Bachem in the development of peptide and protein-based therapeutics.
Bristol-Myers Squibb
BMY
Mkt Cap119.69B
Bristol Myers Squibb is a global biopharmaceutical company that develops peptide and protein-based drugs, competing with Bachem.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap36.77B
Teva Pharmaceutical Industries is a global company that manufactures generic and specialty medicines, including peptide-based therapies, competing with Bachem in the generics and specialty drug market.

About

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
Show more...
CEO
Dr. Anne-Kathrin Stoller Ph.D.
Employees
2130
Country
Switzerland
ISIN
CH1176493729

Listings

SW
CH
BANB.SW
STU
DE
BHM0.STU
MU
DE
BHM0.MU
OTC Link
US
BCHMY

0 Comments

Share your thoughts

FAQ

What is Bachem stock price today?▼
The current price of BHM0.MU is €80.45 EUR — it has decreased by -0.31% in the past 24 hours. Watch Bachem stock price performance more closely on the chart.
What is Bachem stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bachem stocks are traded under the ticker BHM0.MU.
When is the next Bachem earnings date?▼
Bachem is going to release the next earnings report on July 30, 2026.
Does Bachem pay dividends?▼
Yes, BHM0.MU dividends are paid annual. The last dividend per share was 0.46 EUR. As of today, Dividend Yield (FWD)% is 0.6%.
How many employees does Bachem have?▼
As of April 15, 2026, the company has 2,130 employees.
In which sector is Bachem located?▼
Bachem operates in the Materials sector.
When did Bachem complete a stock split?▼
Bachem has not had any recent stock splits.
Where is Bachem headquartered?▼
Bachem is headquartered in Bubendorf, Switzerland.